Intercellular transfer of pathogenic α-synuclein by extracellular vesicles is induced by the lipid peroxidation product 4-hydroxynonenal
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Parkinson’s disease (PD) is characterized by accumulations of toxic α-synuclein aggregates in vulnerable neuronal populations in the brainstem, midbrain and cerebral cortex. Recent findings suggest that α-synuclein pathology can be propagated transneuronally, but the underlying molecular mechanisms are unknown. Advances in the genetics of rare early-onset familial PD indicate that increased production and/or reduced autophagic clearance of α-synuclein can cause PD. The cause of the most common late-onset PD is unclear, but may involve metabolic compromise and oxidative stress upstream of α-synuclein accumulation. As evidence, the lipid peroxidation product 4-hydroxynonenal (HNE) is elevated in the brain during normal aging and moreso in brain regions afflicted with α-synuclein pathology. Here we report that HNE increases aggregation of endogenous α-synuclein in primary neurons, and triggers the secretion of extracellular vesicles (EVs) containing cytotoxic oligomeric α-synuclein species. EVs released from HNE-treated neurons are internalized by healthy neurons which as a consequence degenerate. Levels of endogenously generated HNE are elevated in cultured cells overexpressing human α-synuclein, and EVs released from those cells are toxic to neurons. The EV-associated α-synuclein is located both inside the vesicles, and on their surface where it plays a role in EV internalization by neurons. Upon internalization, EVs harboring pathogenic α-synuclein are transported both anterogradely and retrogradely within axons. Focal injection of EVs containing α-synuclein into the striatum of wild type mice results in spread of synuclein pathology to anatomically connected brain regions. Our findings suggest a scenario for late-onset PD in which lipid peroxidation promotes intracellular accumulation and then extrusion of EVs containing toxic α-synuclein species; the EVs are then internalized by adjacent neurons, so propagating the neurodegenerative process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
Pickrell, A. M., & Youle, R. J. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.007 · Cited by 2,310
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
α-synuclein locus duplication as a cause of familial Parkinson's disease
Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 1×
“Normally, α-synuclein is degraded in proteasomes and by autophagy in lysosomes (Cuervo et al., 2004; Mak et al., 2010; Snyder et al., 2003; Webb et al., 2003; Xilouri et al., 2013).”
BackgroundMice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722
α-Synuclein Is Degraded by Both Autophagy and the Proteasome
Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., & Rubinsztein, D. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300227200 · Cited by 1,429
Braak, H., de Vos, R. A. I., Bohl, J., & Del Tredici, K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.012 · Cited by 1,354 · cited 2×
“pathology spreads transcellularly, and may occur in peripheral neurons before spreading rostrally to the brainstem, and thence to the midbrain and cerebral cortex (Braak et al., 2006; Braak et al., 2003).”
BackgroundIwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., Rohan de Silva, H. A., Kittel, A., & Saitoh, T. (1995) · Neuron · doi:10.1016/0896-6273(95)90302-x · Cited by 1,316 · cited 2×
“…is a highly conserved 140 amino acid presynaptic protein which associates with membranes, and is believed to play a role in the regulation of neurotransmitter release (George et al., 1995; Iwai et al., 1995; Withers et al., 1997; Abeliovich et al., 2000; Burre et al., 2010; Vargas et al., 2014).”
Backgroundα-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
Bartels, T., Choi, J. G., & Selkoe, D. J. (2011) · Nature · doi:10.1038/nature10324 · Cited by 1,263 · cited 2×
“helically folded tetramers that resist aggregation in the cytosol (Bartels et al., 2011).”
BackgroundEmmanouilidou, E., Melachroinou, K., Roumeliotis, T., Garbis, S. D., Ntzouni, M., Margaritis, L. H., Stefanis, L., & Vekrellis, K. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5699-09.2010 · Cited by 1,115 · cited 2×
“EVs secreted by HNE-treated neurons are internalized by and toxic to previously healthy neurons After being released from one cell, EVs can be internalized by neighboring cells (Alvarez-Erviti et al., 2011; Danzer et al., 2012; Emmanouilidou et al., 2010).”
BackgroundImmunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.
Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., & Mizuno, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2696 · Cited by 981
α-Synuclein impairs macroautophagy: implications for Parkinson’s disease
Winslow, A. R., Chen, C.-W., Corrochano, S., Acevedo-Arozena, A., Gordon, D. E., Peden, A. A., Lichtenberg, M., Menzies, F. M., Ravikumar, B., Imarisio, S., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201003122 · Cited by 825 · cited 1×
“…aggregates and neurological deficits similar to PD (Hara et al., 2006; Komatsu et al., 2006), while overexpression of wild type α-synuclein or its mutants inhibits autophagy (Chen et al., 2015; Chew et al., 2011; Choubey et al., 2011; Huang et al., 2012; Koch et al., 2015; Winslow et al., 2010).”
BackgroundVolpicelli-Daley, L. A., Luk, K. C., & Lee, V. M.-Y. (2014) · Nature Protocols · doi:10.1038/nprot.2014.143 · Cited by 731 · cited 1×
“…extracts of PD patient brain, and pathogenic α-synuclein species isolated from the extracts, can trigger the accumulation of endogenous α-synuclein aggregates in the rodent brain (Guo et al., 2013; Mao et al., 2016; Volpicelli-Daley et al., 2014; Volpicelli-Daley et al., 2011; Luk et al., 2012).”
BackgroundDistinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons
Guo, J. L., Covell, D. J., Daniels, J. P., Iba, M., Stieber, A., Zhang, B., Riddle, D. M., Kwong, L. K., Xu, Y., Trojanowski, J. Q., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.057 · Cited by 680 · cited 1×
“…extracts of PD patient brain, and pathogenic α-synuclein species isolated from the extracts, can trigger the accumulation of endogenous α-synuclein aggregates in the rodent brain (Guo et al., 2013; Mao et al., 2016; Volpicelli-Daley et al., 2014; Volpicelli-Daley et al., 2011; Luk et al., 2012).”
Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors
Klingelhoefer, L., & Reichmann, H. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.197 · Cited by 598
Mark, R. J., Pang, Z., Geddes, J. W., Uchida, K., & Mattson, M. P. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-03-01046.1997 · Cited by 551 · cited 2×
“For example, studies relevant to Alzheimer’s disease have shown that pathogenic forms of amyloid β-peptide can cause membrane lipid peroxidation and consequent destabilization of neuronal ion homeostasis and energy metabolism (Mark et al., 1995; Mark et al., 1997; Keller et al., 1997).”
BackgroundSelf-citationMitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease
Ryan, B. J., Hoek, S., Fon, E. A., & Wade-Martins, R. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.02.003 · Cited by 524 · cited 2×
“Moreover, mutations in multiple genes that cause early-onset inherited PD (α-synuclein, Parkin, PINK1, DJ-1 and LRRK2) result, either directly or indirectly, in mitochondrial dysfunction (Pickrell and Youle, 2015; Ryan et al., 2015; Bose and Beal, 2016).”
BackgroundOxidative stress and aberrant signaling in aging and cognitive decline
Dröge, W., & Schipper, H. M. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00294.x · Cited by 479 · cited 1×
“…including covalent modification by HNE, occurs during normal aging, and is greatly exacerbated in vulnerable brain regions of PD patients and animal models of PD (Dexter et al., 1989; Castellani et al., 2002; Droge and Schipper, 2007; Di Domenico et al., 2016; Plotegher and Bubacco, 2016).”
BackgroundPhosphorylated α-Synuclein Is Ubiquitinated in α-Synucleinopathy Lesions
Hasegawa, M., Fujiwara, H., Nonaka, T., Wakabayashi, K., Takahashi, H., Lee, V. M.-Y., Trojanowski, J. Q., Mann, D., & Iwatsubo, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208046200 · Cited by 428 · cited 2×
“…to ubiquitination (Lee et al., 2008b; Nonaka et al., 2005), αsynuclein can be post-translationally modified by phosphorylation (Anderson et al., 2006; Hasegawa et al., 2002; Okochi et al., 2000) and acetylation (Trexler and Rhoades, 2012), which may influence its aggregation and degradation.”
BackgroundWakabayashi, K., Hayashi, S., Kakita, A., Yamada, M., Toyoshima, Y., Yoshimoto, M., & Takahashi, H. (1998) · Acta Neuropathologica · doi:10.1007/s004010050918 · Cited by 347 · cited 1×
“…soma (Lewy bodies) and neurites (Baba et al., 1998; Jellinger, 2011; Spillantini et al., 1998a; Spillantini et al., 1998b; Spillantini et al., 1997; Wakabayashi et al., 1998). α-synuclein is a highly conserved 140 amino acid presynaptic protein which associates with membranes, and is believed to…”
BackgroundDi Domenico, F., Tramutola, A., & Butterfield, D. A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.490 · Cited by 253
Assessment of α-Synuclein Secretion in Mouse and Human Brain Parenchyma
Emmanouilidou, E., Elenis, D., Papasilekas, T., Stranjalis, G., Gerozissis, K., Ioannou, P. C., & Vekrellis, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022225 · Cited by 163 · cited 1×
“Similar to a recent study (Emmanouilidou et al., 2011; Danzer et al., 2012), we found that a cell line overexpressing human α-synuclein releases EVs that contain α-synuclein aggregates, and we further found that primary cortical neurons exposed to HNE release EVs harboring α-synuclein.”
ResultShringarpure, R., Grune, T., Sitte, N., & Davies*, K. J. A. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000660 · Cited by 140
Cited by
Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States
Mattson, M. P., & Arumugam, T. V. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.011 · Cited by 1,242
“…and oxidative stress can trigger the release of EVs containing aggregating a-synuclein, and those EVs can then be internalized and trigger the accumulation of toxic a-synuclein aggregates in previously healthy neurons (Emmanouilidou et al., 2010; Poehler et al., 2014; Zhang et al., 2018).”
BackgroundSelf-citationBidirectional Microglia–Neuron Communication in Health and Disease
Szepesi, Z., Manouchehrian, O., Bachiller, S., & Deierborg, T. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00323 · Cited by 459
Czubowicz, K., Jęśko, H., Wencel, P., Lukiw, W. J., & Strosznajder, R. P. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1448-3 · Cited by 281
Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
Brás, I. C., & Outeiro, T. F. (2021) · Cells · doi:10.3390/cells10020375 · Cited by 136
Raefsky, S. M., Furman, R., Milne, G., Pollock, E., Axelsen, P., Mattson, M. P., & Shchepinov, M. S. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.02.024 · Cited by 90
Self-citation
Metadata
- Authors
- Zhang, S., Eitan, E., Wu, T.-Y., & Mattson, M. P.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 61
- Pages
- 52-65
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2759137336
- Cited by
- 73
- References
- 23
- FWCI
- 4.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.